Active	Status	Sponsor type	Region	Phase	Filter
13 Active 3 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Trebicka, Jonel
PRECIOSA, NCT03451292 / 2016-001789-28: Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites	Completed	3	410	Europe, Canada, US, RoW	Albutein 20% Injectable Solution, Standard medical treatment	Grifols Therapeutics LLC, Instituto Grifols, S.A.	Decompensated Cirrhosis and Ascites	05/24	05/24
NCT04950127 / 2021-000007-21: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)	Active, not recruiting	3	238	Europe, Canada, Japan, US, RoW	Linerixibat, Placebo	GlaxoSmithKline	Pruritus	10/24	01/25
APACHE, NCT03702920 / 2016-001787-10: Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%	Recruiting	3	380	Europe, US	SMT + PE-A 5%, Albutein 5%, Standard Medical Treatment, SMT	Grifols Therapeutics LLC, Instituto Grifols, S.A.	Acute-On-Chronic Liver Failure	10/26	10/26
LLSAT, NCT04167358 / 2019-003158-10: Linerixibat Long-term Safety, and Tolerability Study	Recruiting	3	251	Europe, Canada, Japan, US, RoW	Linerixibat	GlaxoSmithKline, GlaxoSmithKline LLC, GlaxoSmithKline Research & Development Limited	Cholestasis	02/27	02/27
NCT05661331: VIATORR Device Registry	Recruiting	N/A	196	Europe	Transjugular intrahepatic portosystemic shunt, TIPS	W.L.Gore & Associates	Chronic Liver Disease	01/25	01/28